Álvaro Andrades

9PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 01, 2025
High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models.

Juan Carlos Álvarez-Pérez, Juan Sanjuán-Hidalgo, Alberto M Arenas

|Jun 08, 2023
Tumour mutations in long noncoding RNAs enhance cell fitness.

Roberta Esposito, Andrés Lanzós, Tina Uroda

|Dec 16, 2020
Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models.

Paola Peinado, Alvaro Andrades, Marta Cuadros

|Aug 01, 2020
LncRNA DLG2-AS1 as a Novel Biomarker in Lung Adenocarcinoma.

Alberto M Arenas, Marta Cuadros, Alvaro Andrades

|Jun 25, 2020
Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.

Carlos Baliñas-Gavira, María I Rodríguez, Alvaro Andrades

Pageof 2